US Stock MarketDetailed Quotes
CGEM Cullinan Therapeutics
- 18.890
- +2.220+13.32%
Close Apr 24 16:00 ET
- 18.880
- -0.010-0.05%
Post 19:34 ET
813.51MMarket Cap-5119P/E (TTM)
19.550High16.530Low1.17MVolume16.690Open16.670Pre Close21.66MTurnover4.54%Turnover RatioLossP/E (Static)43.07MShares20.62052wk High1.79P/B488.78MFloat Cap7.64052wk Low--Dividend TTM25.88MShs Float59.850Historical High--Div YieldTTM18.12%Amplitude7.300Historical Low18.449Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Cullinan Therapeutics Stock Forum
NEWS
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
ColumnsToday's pre-market stock movers: BYND, DIS, F, GM and more
• $Cullinan Therapeutics(CGEM.US)$ +22.4% (Cullinan Management and Taiho Pharmaceutical to collaborate to jointly develop and commercialize CLN081/TAS6417 and Taiho's acquisition of Cullinan Pearl)
• $Lordstown Motors(RIDE.US)$ +17.2% (closes asset purchase agreement with Foxconn)
• $Applovin(APP.US)$ +15.5%(In reaction to earnings)
• $SmartRent(SMRT.US)$ +15.4%(In reaction to earnings)
• $Coupang(CPNG.US)$ +14.3%(In reaction to earn...
No comment yet